by aegros admin / News & Press

Israel Ministry of Economy & Industry Awards Aegros 10.4m NIS grant

expose-seperator

 

FOR IMMEDIATE RELEASE

 

Sydney, Australia 1st December 2018 – The Board of Aegros is delighted to advise that the Ministry of Economy & Industry of Israel has awarded Aegros up to 10.4m NIS (US$3m) investment grant. This grant covers 20% of the capital Aegros will invest up to 52m NIS. This was a competitive grant and Aegros was one of the few companies to be given this grant in the current round.

Aegros was awarded this grant to purchase equipment for the fractionation facility it is acquiring in Har Hotzvim, Jerusalem. Aegros is grateful to the Israeli government for its confidence in the introduction of a full fractionation plant in Jerusalem with its patented CyMES technology.

Aegros is acquiring this fractionation facility in Har Hotzvim in order to establish its first CyMES fractionation facility to manufacture Albumin and IVIG.

This facility was previously owned by Omrix, a subsidiary of Johnson & Johnson. This facility was constructed by BioPharmax in 2012 for an estimated cost of US$60m.

**ENDS**

For more information please contact:
Contact:
Dr Hari Nair
Aegros
+61 2 9683 8673
Hari.nair@aegros.com.au

 

About Aegros

Our mission is to develop and become the market leader in the emerging therapeutic plasma markets. The Company will achieve this by integrating the multi patent pending CyMES with existing processes to deliver safer & more affordable therapeutic plasma products.

At Aegros we believe, access to these life saving drugs is a human right and not a privilege. In a nutshell, at Aegros, our mission is to put the Patient 1st through innovation.

www.aegros.com.au